Kearny Financial Corp. (KRNY) EVP reports 12,240-share grant and tax withholding
Rhea-AI Filing Summary
Kearny Financial Corp. EVP and CCO Thomas DeMedici reported a grant of 12,240 shares of common stock on August 7, 2025 and a tax-withholding disposition of 1,879 shares at $5.86 per share. Following these transactions, he holds 80,994 common shares directly and stock options covering 150,000 underlying shares, plus indirect holdings of common stock through a 401(k), ESOP and BEP, some of which consist of restricted stock units vesting 33% annually beginning on August 7 in 2023–2026.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider reported RSU grants and a small open-market acquisition; 150,000 options outstanding—overall a routine compensation and ownership update.
The Form 4 shows Thomas DeMedici received 12,240 RSUs (priced $0) with staged vesting and acquired 1,879 shares at $5.86 on 08/07/2025. The report additionally lists 100,000 and 50,000 stock options with stated exercise prices and expirations. Indirect plan holdings are disclosed for 401(k), ESOP and BEP accounts. From an investor perspective, these are factual disclosures of compensation and holdings; the filing does not by itself indicate a material change to capitalization or a corporate event.
TL;DR: Filing documents multi-year RSU vesting vintages and retirement-plan holdings, reflecting executive compensation structure rather than a material corporate action.
The explanations explicitly state RSUs vest at a rate of 33% per year commencing on specified August 7 dates, indicating staged compensation recognition across multiple grant years. The presence of 48,189 shares held indirectly in a 401(k) and 24,968 via an ESOP is documented. The filing is a standard Section 16 disclosure showing ownership and option positions; it contains no disclosures of leadership change, securitization, or litigation that would alter governance assessment.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 12,240 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 1,879 | $5.86 | $11K |
| holding | Stock Options | -- | -- | -- |
| holding | Stock Options | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (5)
- F1. Restricted stock units which vest at a rate of 33% per year commencing on August 7, 2026.
- F2. Includes restricted stock units which vest at a rate of 33% per year commencing on August 7, 2025.
- F3. Includes restricted stock units which vest at a rate of 33% per year commencing on August 7, 2024.
- F4. Includes restricted stock units which vest at a rate of 33% per year commencing on August 7, 2023.
- F5. Reflects transactions not required to be reported pursuant to Section 16 of the Securities Exchange Act of 1934, as amended.
Key Figures
Key Terms
restricted stock units financial
401(k) financial
ESOP financial
BEP financial
Section 16 of the Securities Exchange Act of 1934 regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.